Targeting miR-25 to alleviate DMD-related muscle dysfunction

dc.contributor.author	Li, Shuang
dc.contributor.author	Han, Renzhi
dc.contributor.department	Pediatrics, School of Medicine
dc.date.accessioned	2024-09-17T13:52:41Z
dc.date.available	2024-09-17T13:52:41Z
dc.date.issued	2024-06-17
dc.eprint.version	Final published version
dc.identifier.citation	Li S, Han R. Targeting miR-25 to alleviate DMD-related muscle dysfunction. Mol Ther Nucleic Acids. 2024;35(3):102238. Published 2024 Jun 17. doi:10.1016/j.omtn.2024.102238
dc.identifier.uri	https://hdl.handle.net/1805/43368
dc.language.iso	en_US
dc.publisher	Elsevier
dc.relation.isversionof	10.1016/j.omtn.2024.102238
dc.relation.journal	Molecular Therapy: Nucleic Acids
dc.rights	Attribution 4.0 International	en
dc.rights.uri	https://creativecommons.org/licenses/by/4.0
dc.source	PMC
dc.subject	Duchenne muscular dystrophy (DMD)
dc.subject	Dystrophin expression
dc.subject	MicroRNA-25 (miR-25)
dc.title	Targeting miR-25 to alleviate DMD-related muscle dysfunction
dc.type	Article